Literature references that cite this PDB file's
key reference
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.J.Barr,
E.Ugochukwu,
W.H.Lee,
O.N.King,
P.Filippakopoulos,
I.Alfano,
P.Savitsky,
N.A.Burgess-Brown,
S.Müller,
and
S.Knapp
(2009).
Large-scale structural analysis of the classical human protein tyrosine phosphatome.
|
| |
Cell, 136,
352-363.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.J.Beresford,
D.Mulhearn,
B.Szczepankiewicz,
G.Liu,
M.E.Johnson,
A.Fordham-Skelton,
C.Abad-Zapatero,
J.S.Cavet,
and
L.Tabernero
(2009).
Inhibition of MptpB phosphatase from Mycobacterium tuberculosis impairs mycobacterial survival in macrophages.
|
| |
J Antimicrob Chemother, 63,
928-936.
|
 |
|
|
|
|
 |
R.Maccari,
R.Ottanà,
R.Ciurleo,
P.Paoli,
G.Manao,
G.Camici,
C.Laggner,
and
T.Langer
(2009).
Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
|
| |
ChemMedChem, 4,
957-962.
|
 |
|
|
|
|
 |
R.Srinivasan,
L.P.Tan,
H.Wu,
P.Y.Yang,
K.A.Kalesh,
and
S.Q.Yao
(2009).
High-throughput synthesis of azide libraries suitable for direct "click" chemistry and in situ screening.
|
| |
Org Biomol Chem, 7,
1821-1828.
|
 |
|
|
|
|
 |
A.Bakan,
J.S.Lazo,
P.Wipf,
K.M.Brummond,
and
I.Bahar
(2008).
Toward a molecular understanding of the interaction of dual specificity phosphatases with substrates: insights from structure-based modeling and high throughput screening.
|
| |
Curr Med Chem, 15,
2536-2544.
|
 |
|
|
|
|
 |
K.Bharatham,
N.Bharatham,
Y.J.Kwon,
and
K.W.Lee
(2008).
Molecular dynamics simulation study of PTP1B with allosteric inhibitor and its application in receptor based pharmacophore modeling.
|
| |
J Comput Aided Mol Des, 22,
925-933.
|
 |
|
|
|
|
 |
L.Tabernero,
A.R.Aricescu,
E.Y.Jones,
and
S.E.Szedlacsek
(2008).
Protein tyrosine phosphatases: structure-function relationships.
|
| |
FEBS J, 275,
867-882.
|
 |
|
|
|
|
 |
A.K.Nordle,
P.Rios,
A.Gaulton,
R.Pulido,
T.K.Attwood,
and
L.Tabernero
(2007).
Functional assignment of MAPK phosphatase domains.
|
| |
Proteins, 69,
19-31.
|
 |
|
|
|
|
 |
J.Xie,
and
C.T.Seto
(2007).
A two stage click-based library of protein tyrosine phosphatase inhibitors.
|
| |
Bioorg Med Chem, 15,
458-473.
|
 |
|
|
|
|
 |
M.Stuible,
L.Zhao,
I.Aubry,
D.Schmidt-Arras,
F.D.Böhmer,
C.J.Li,
and
M.L.Tremblay
(2007).
Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
|
| |
Chembiochem, 8,
179-186.
|
 |
|
|
|
|
 |
S.C.Almo,
J.B.Bonanno,
J.M.Sauder,
S.Emtage,
T.P.Dilorenzo,
V.Malashkevich,
S.R.Wasserman,
S.Swaminathan,
S.Eswaramoorthy,
R.Agarwal,
D.Kumaran,
M.Madegowda,
S.Ragumani,
Y.Patskovsky,
J.Alvarado,
U.A.Ramagopal,
J.Faber-Barata,
M.R.Chance,
A.Sali,
A.Fiser,
Z.Y.Zhang,
D.S.Lawrence,
and
S.K.Burley
(2007).
Structural genomics of protein phosphatases.
|
| |
J Struct Funct Genomics, 8,
121-140.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
X.Tao,
and
L.Tong
(2007).
Crystal structure of the MAP kinase binding domain and the catalytic domain of human MKP5.
|
| |
Protein Sci, 16,
880-886.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
X.Yu,
J.P.Sun,
Y.He,
X.Guo,
S.Liu,
B.Zhou,
A.Hudmon,
and
Z.Y.Zhang
(2007).
Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.
|
| |
Proc Natl Acad Sci U S A, 104,
19767-19772.
|
 |
|
|
|
|
 |
A.J.Barr,
J.E.Debreczeni,
J.Eswaran,
and
S.Knapp
(2006).
Crystal structure of human protein tyrosine phosphatase 14 (PTPN14) at 1.65-A resolution.
|
| |
Proteins, 63,
1132-1136.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Tolkatchev,
R.Shaykhutdinov,
P.Xu,
J.Plamondon,
D.C.Watson,
N.M.Young,
and
F.Ni
(2006).
Three-dimensional structure and ligand interactions of the low molecular weight protein tyrosine phosphatase from Campylobacter jejuni.
|
| |
Protein Sci, 15,
2381-2394.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.X.Liu,
J.Z.Tan,
C.Y.Niu,
J.H.Shen,
X.M.Luo,
X.Shen,
K.X.Chen,
and
H.L.Jiang
(2006).
Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor.
|
| |
Acta Pharmacol Sin, 27,
100-110.
|
 |
|
|
|
|
 |
L.Milanesi,
C.A.Hunter,
S.E.Sedelnikova,
and
J.P.Waltho
(2006).
Amplification of bifunctional ligands for calmodulin from a dynamic combinatorial library.
|
| |
Chemistry, 12,
1081-1087.
|
 |
|
|
|
|
 |
R.A.Judge,
K.Swift,
and
C.González
(2005).
An ultraviolet fluorescence-based method for identifying and distinguishing protein crystals.
|
| |
Acta Crystallogr D Biol Crystallogr, 61,
60-66.
|
 |
|
|
|
|
 |
R.G.Coleman,
M.A.Burr,
D.L.Souvaine,
and
A.C.Cheng
(2005).
An intuitive approach to measuring protein surface curvature.
|
| |
Proteins, 61,
1068-1074.
|
 |
|
|
|
|
 |
U.Schieborr,
M.Vogtherr,
B.Elshorst,
M.Betz,
S.Grimme,
B.Pescatore,
T.Langer,
K.Saxena,
and
H.Schwalbe
(2005).
How much NMR data is required to determine a protein-ligand complex structure?
|
| |
Chembiochem, 6,
1891-1898.
|
 |
|
|
|
|
 |
C.Wiesmann,
K.J.Barr,
J.Kung,
J.Zhu,
D.A.Erlanson,
W.Shen,
B.J.Fahr,
M.Zhong,
L.Taylor,
M.Randal,
R.S.McDowell,
and
S.K.Hansen
(2004).
Allosteric inhibition of protein tyrosine phosphatase 1B.
|
| |
Nat Struct Mol Biol, 11,
730-737.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.D.Taylor,
and
B.Hill
(2004).
Recent advances in protein tyrosine phosphatase 1B inhibitors.
|
| |
Expert Opin Investig Drugs, 13,
199-214.
|
 |
|
|
|
|
 |
A.Nayeem,
S.Krystek,
and
T.Stouch
(2003).
An assessment of protein-ligand binding site polarizability.
|
| |
Biopolymers, 70,
201-211.
|
 |
|
|
|
|
 |
Z.Y.Zhang,
and
S.Y.Lee
(2003).
PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity.
|
| |
Expert Opin Investig Drugs, 12,
223-233.
|
 |
|
|
|
|
 |
H.Fu,
J.Park,
and
D.Pei
(2002).
Peptidyl aldehydes as reversible covalent inhibitors of protein tyrosine phosphatases.
|
| |
Biochemistry, 41,
10700-10709.
|
 |
|
|
|
|
 |
L.Xie,
Y.L.Zhang,
and
Z.Y.Zhang
(2002).
Design and characterization of an improved protein tyrosine phosphatase substrate-trapping mutant.
|
| |
Biochemistry, 41,
4032-4039.
|
 |
|
|
|
|
 |
T.O.Johnson,
J.Ermolieff,
and
M.R.Jirousek
(2002).
Protein tyrosine phosphatase 1B inhibitors for diabetes.
|
| |
Nat Rev Drug Discov, 1,
696-709.
|
 |
|
|
|
|
 |
Z.Y.Zhang
(2002).
Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.
|
| |
Annu Rev Pharmacol Toxicol, 42,
209-234.
|
 |
|
|
|
|
 |
G.Scapin,
S.Patel,
V.Patel,
B.Kennedy,
and
E.Asante-Appiah
(2001).
The structure of apo protein-tyrosine phosphatase 1B C215S mutant: more than just an S --> O change.
|
| |
Protein Sci, 10,
1596-1605.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.N.Andersen,
O.H.Mortensen,
G.H.Peters,
P.G.Drake,
L.F.Iversen,
O.H.Olsen,
P.G.Jansen,
H.S.Andersen,
N.K.Tonks,
and
N.P.Møller
(2001).
Structural and evolutionary relationships among protein tyrosine phosphatase domains.
|
| |
Mol Cell Biol, 21,
7117-7136.
|
 |
|
|
|
|
 |
M.Sarmiento,
Y.A.Puius,
S.W.Vetter,
Y.F.Keng,
L.Wu,
Y.Zhao,
D.S.Lawrence,
S.C.Almo,
and
Z.Y.Zhang
(2000).
Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition.
|
| |
Biochemistry, 39,
8171-8179.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.A.Puius,
E.V.Fedorov,
L.Eichinger,
M.Schleicher,
and
S.C.Almo
(2000).
Mapping the functional surface of domain 2 in the gelsolin superfamily.
|
| |
Biochemistry, 39,
5322-5331.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Chen,
L.N.Cong,
Y.Li,
Z.J.Yao,
L.Wu,
Z.Y.Zhang,
T.R.Burke,
and
M.J.Quon
(1999).
A phosphotyrosyl mimetic peptide reverses impairment of insulin-stimulated translocation of GLUT4 caused by overexpression of PTP1B in rat adipose cells.
|
| |
Biochemistry, 38,
384-389.
|
 |
|
|
|
|
 |
J.L.Evans,
and
B.Jallal
(1999).
Protein tyrosine phosphatases: their role in insulin action and potential as drug targets.
|
| |
Expert Opin Investig Drugs, 8,
139-160.
|
 |
|
|
|
|
 |
N.R.Glover,
and
A.S.Tracey
(1999).
Nuclear magnetic resonance and restrained molecular dynamics studies of the interaction of an epidermal growth factor-derived peptide with protein tyrosine phosphatase 1B.
|
| |
Biochemistry, 38,
5256-5271.
|
 |
|
|
|
|
 |
M.R.Groves,
Z.J.Yao,
P.P.Roller,
T.R.Burke,
and
D.Barford
(1998).
Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics.
|
| |
Biochemistry, 37,
17773-17783.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|